您要查找的是不是:
- Objective To discuss the correlation of CT appearances and the angiogenesis(VEGF,MVD) in small cell lung cancer(SCLC). 目的探讨小细胞肺癌(SCLC)的CT征象和血管内皮生长因子(VEGF)、微血管密度(MVD)的相关性。
- There were no expression of cerbB2 and nm23H1 oncoprotein in 10 small cell lung carcinoma (SCLC). c?erbB?2与nm23?H1在10例小细胞肺癌(SCLC)中未见表达。
- Objective: To evaluate the diagnostic significance of CT findings in small cell lung cancer (SCLC). 目的:探讨小细胞肺癌(SCLC)的CT表现与诊断。
- To observe the effect and toxicity of topotecan in the treatment for small cell lung cancer(SCLC). 观察拓朴替康治疗小细胞肺癌的疗效和毒副反应。
- The main pathology type is small cell lung cancer(SCLC) and non-small cell lung cancer(NSCLC). 病理类型以小细胞肺癌和非小细胞肺癌为主。
- Abstract: Paraneoplastic opsoclonus-myoclonus syndrome (OMS) is associated with small cell lung cancer (SCLC) in adults. 成年人的副肿瘤性眼阵挛-肌阵挛综合征(OMS)与小细胞肺癌(SCLC)有关。
- Objective To observe the relation of traditional Chinese medicine (TCM) syndromes of advanced small cell lung cancer (SCLC) and quality of life (QOL). 目的探讨晚期小细胞肺癌的中医证候与生存质量的关系。
- Small cell lung cancer(SCLC) is a type of lung cancer classified by pathobiology.SCLC constitutes approximately 20% of all lung cancer. 小细胞肺癌是肺癌的一种病理学分类,约占肺癌的20%25,小细胞肺癌的治疗方案一般为化疗和放疗联合方案;
- Purpose To discuss the relationship between the change of p53 gene and the expression of murine double minute 2 (mdm 2) gene protein in small cell lung cancer (SCLC). 目的:探讨肺小细胞癌( S C L C) 的p53 基因改变与mdm?2 基因蛋白表达的关系。
- BACKGROUND: Small cell lung cancer (SCLC) is a ery aggressie disease, with poor surial rates despite standard treatment with combination chemotherapy with or without radiotherapy. 背景:小细胞肺癌(SCLC)是一种非常有侵袭性的疾病,虽然通过标准治疗加上联合化疗再加上或不加放射治疗,存活率不高。
- Objective To investigate the expression of osteopontin(OPN) and its correlation with lymph node metastases and pathologic features of small cell lung cancer(SCLC). 目的研究骨桥蛋白(OPN)在小细胞肺癌(SCLC)中的表达及其与肺癌转移的关系。方法应用免疫组化法检测23例患者肺癌组织中OPN的表达,以18例正常肺组织作为对照。
- BACKGROUND: Small cell lung cancer (SCLC) is a very aggressive disease, with poor survival rates despite standard treatment with combination chemotherapy with or without radiotherapy. 背景:小细胞肺癌(SCLC)是一种非常有侵袭性的疾病,虽然通过标准治疗加上联合化疗再加上或不加放射治疗,存活率不高。
- Common in small cell lung cancer, adenocarcinoma type. 常见于小细胞肺癌、腺癌类型。
- The results showed that the expression of CD44s or CD44v6 in 41 non-small cell lung cancer (NSCLC) cases were 70.7% and 9.7%, respectively, but no CD44s or CD44v6 expressed in 15 small cell lung cancer(SCLC)cas- es. 结果:41例非小细胞肺癌(NSCLC)包括鳞癌、腺癌、大细胞癌的 CC44h4s表达率为 70.;7%25, CIM4v6的表达率为9
- The Rb gene abnormality was one of the hereditary factors associated with the occurrence of lung cancer, and the abnormal Rb gene was found in 90% of small cell lung cancer (SCLC) and 10 -30% of non - small cell lung cancer ( NSCLC). 在小细胞肺癌(SCLC)约90%25,非小细胞肺癌(NSCLC)约10-30%25存在Rb基因异常,Rb基因异常者因肺癌死亡的危险性比正常人高15倍,是肺癌发生的遗传因素之一。
- Compares with non-small cell lung cancer,small cell lung cancer (SCLC) generally has a more rapid doubling time,a higher growth fraction,and earlier development of widespread metastases. 与非小细胞肺癌相比较,小细胞肺癌具有更快的肿瘤倍增时间、快速生长以及易于早期转移的特点。
- BACKGROUND.The use of prophylactic cranial irradiation (PCI) in patients with small cell lung cancer (SCLC) has been tempered by fears of detrimental effects on cognitive function. 背景:由于对认知功能的不利影响,小细胞肺癌(SCLC)患者的预防性头颅放疗(PCI)运用得少了。
- Compares with non-small cell lung cancer, small cell lung cancer (SCLC) generally has a more rapid doubling time, a higher growth fraction, and earlier development of widespread metastases. 摘要与非小细胞肺癌相比较,小细胞肺癌具有更快的肿瘤倍增时间、快速生长以及易于早期转移的特点。
- Objective: To summarize and analyze the CT features , approach and result of pathologic diagnosis in small cell lung cancer (SCLC), and study the correlation of radiologic and pathologic basis. 目的:总结分析小细胞肺癌的CT表现特点、病理诊断途径及其结果,以加强对本病的病理基础与影像表现关系的认识。
- Aim To evaluate the therapeutic efficiency of Ad-hTRAIL (the replication-defective adenovirus expressing recombinant human TRAIL gene) on human small cell lung cancer (SCLC) cell line H446 in vitro. 目的评价携带人TRAIL基因的腺病毒载体对人小细胞肺癌细胞株H446的基因治疗功效。
